✦ LIBER ✦

Type II Kinase Inhibitors: An Opportunity in Cancer for Rational Design

✍ Scribed by Blanc, Javier; Geney, Raphael; Menet, Christel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polo-like kinase inhibitors: an emerging

✍ Chopra, Puneet; Sethi, Gautam; Dastidar, Sunanda G; Ray, Abhijit 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 744 KB

Casein Kinase II: An attractive target f

✍ Ismail Muhamad Hanif; Ibrahim Muhammad Hanif; Muhammad Ali Shazib; Kashif Adil A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 250 KB

H89, an inhibitor of protein kinase A (P

✍ Yoshinori Marunaka; Naomi Niisato 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 126 KB

A Phase II Trial of Saracatinib, an Inhi

✍ Laurie, Scott A.; Goss, Glenwood D.; Shepherd, Frances A.; Reaume, M. Neil; Nich 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 205 KB

Clinical Implications of KRAS Mutations

✍ Marchetti, Antonio; Milella, Michele; Felicioni, Lara; Cappuzzo, Federico; Irtel 📂 Article 📅 2009 🏛 Neoplasia Press 🌐 English ⚖ 453 KB

A multicenter phase II study of TSU-68,

✍ Masakazu Toi, Toshiaki Saeki, Hiroji Iwata, Kenichi Inoue, Yutaka Tokuda… 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 235 KB